Page last updated: 2024-10-21

3-methylcholanthrene and Prostatic Diseases

3-methylcholanthrene has been researched along with Prostatic Diseases in 1 studies

Methylcholanthrene: A carcinogen that is often used in experimental cancer studies.
3-methylcholanthrene : A pentacyclic ortho- and peri-fused polycyclic arene consisting of a dihydrocyclopenta[ij]tetraphene ring system with a methyl substituent at the 3-position.

Prostatic Diseases: Pathological processes involving the PROSTATE or its component tissues.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chopra, DP1
Wilkoff, LJ1

Other Studies

1 other study available for 3-methylcholanthrene and Prostatic Diseases

ArticleYear
Inhibition and reversal by beta-retinoic acid of hyperplasia induced in cultured mouse prostate tissue by 3-methylcholanthrene or N-methyl-N'-nitro-N-nitrosoguanidine.
    Journal of the National Cancer Institute, 1976, Volume: 56, Issue:3

    Topics: Animals; Cell Division; Epithelial Cells; Epithelium; Hyperplasia; Male; Methylcholanthrene; Methyln

1976